# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-087428
Filing Date
2022-03-29
Accepted
2022-03-29 07:43:04
Documents
47
Period of Report
2022-03-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d316282d8k.htm iXBRL | 8-K | 25966
2 | EX-99.1 | d316282dex991.htm | EX-99.1 | 41208
6 | GRAPHIC | g316282page001.jpg | GRAPHIC | 32520
7 | GRAPHIC | g316282page002.jpg | GRAPHIC | 98309
8 | GRAPHIC | g316282page003.jpg | GRAPHIC | 33393
9 | GRAPHIC | g316282page004.jpg | GRAPHIC | 43996
10 | GRAPHIC | g316282page005.jpg | GRAPHIC | 32330
11 | GRAPHIC | g316282page006.jpg | GRAPHIC | 38456
12 | GRAPHIC | g316282page007.jpg | GRAPHIC | 21347
13 | GRAPHIC | g316282page008.jpg | GRAPHIC | 38532
14 | GRAPHIC | g316282page009.jpg | GRAPHIC | 52089
15 | GRAPHIC | g316282page010.jpg | GRAPHIC | 46956
16 | GRAPHIC | g316282page011.jpg | GRAPHIC | 48350
17 | GRAPHIC | g316282page012.jpg | GRAPHIC | 42023
18 | GRAPHIC | g316282page013.jpg | GRAPHIC | 36105
19 | GRAPHIC | g316282page014.jpg | GRAPHIC | 45639
20 | GRAPHIC | g316282page015.jpg | GRAPHIC | 45583
21 | GRAPHIC | g316282page016.jpg | GRAPHIC | 33380
22 | GRAPHIC | g316282page017.jpg | GRAPHIC | 38501
23 | GRAPHIC | g316282page018.jpg | GRAPHIC | 31261
24 | GRAPHIC | g316282page019.jpg | GRAPHIC | 39819
25 | GRAPHIC | g316282page020.jpg | GRAPHIC | 30978
26 | GRAPHIC | g316282page021.jpg | GRAPHIC | 45890
27 | GRAPHIC | g316282page022.jpg | GRAPHIC | 23092
28 | GRAPHIC | g316282page023.jpg | GRAPHIC | 46657
29 | GRAPHIC | g316282page024.jpg | GRAPHIC | 46674
30 | GRAPHIC | g316282page025.jpg | GRAPHIC | 43384
31 | GRAPHIC | g316282page026.jpg | GRAPHIC | 57597
32 | GRAPHIC | g316282page027.jpg | GRAPHIC | 49116
33 | GRAPHIC | g316282page028.jpg | GRAPHIC | 49995
34 | GRAPHIC | g316282page029.jpg | GRAPHIC | 46869
35 | GRAPHIC | g316282page030.jpg | GRAPHIC | 49050
36 | GRAPHIC | g316282page031.jpg | GRAPHIC | 48027
37 | GRAPHIC | g316282page032.jpg | GRAPHIC | 41689
38 | GRAPHIC | g316282page033.jpg | GRAPHIC | 33430
39 | GRAPHIC | g316282page034.jpg | GRAPHIC | 25634
| Complete submission text file | 0001193125-22-087428.txt |  | 2189068

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | elym-20220328.xsd | EX-101.SCH | 2845
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | elym-20220328_lab.xml | EX-101.LAB | 18738
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | elym-20220328_pre.xml | EX-101.PRE | 11700
41 | EXTRACTED XBRL INSTANCE DOCUMENT | d316282d8k_htm.xml | XML | 3483

Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 22777385
SIC: 2834 Pharmaceutical Preparations